These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6311525)

  • 1. Interactions of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies.
    Skerritt JH; Davies LP; Johnston GA
    Epilepsia; 1983 Oct; 24(5):634-42. PubMed ID: 6311525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazolo[3,4-d]pyrimidines as adenosine antagonists.
    Davies LP; Chow SC; Skerritt JH; Brown DJ; Johnston GA
    Life Sci; 1984 May; 34(22):2117-28. PubMed ID: 6328156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo.
    Davies LP; Baird-Lambert J; Marwood JF
    Biochem Pharmacol; 1986 Sep; 35(18):3021-9. PubMed ID: 3019353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.
    Hüttemann E; Ukena D; Lenschow V; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):226-33. PubMed ID: 6328333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A purinergic component in the anticonvulsant action of carbamazepine?
    Skeritt JH; Davies LP; Johnston GA
    Eur J Pharmacol; 1982 Aug; 82(3-4):195-7. PubMed ID: 7128687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF; Lu GH; Pugsley TA
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of N6-[3H]cyclohexyladenosine binding by carbamazepine.
    Weir RL; Anderson SM; Daly JW
    Epilepsia; 1990; 31(5):503-12. PubMed ID: 2401242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 5'-N-ethylcarboxamido[3H]adenosine binding to pig aorta smooth muscle membranes.
    Diocee BK; Souness JE
    Biochem Pharmacol; 1987 Nov; 36(21):3621-7. PubMed ID: 2823828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of several 5'-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells.
    Ukena D; Böhme E; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):36-42. PubMed ID: 6092968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of adenosine receptors in brain. Characterization by 2-chloro[3H]adenosine binding.
    Chin JH; DeLorenzo RJ
    Biochem Pharmacol; 1986 Mar; 35(5):847-56. PubMed ID: 3006693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors.
    Fujiwara Y; Sato M; Otsuki S
    Psychopharmacology (Berl); 1986; 90(3):332-5. PubMed ID: 3097720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an A2 adenosine receptor in guinea pig lung.
    Ukena D; Schirren CG; Klotz KN; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):89-95. PubMed ID: 2999618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selective binding site for 3H-NECA that is not an adenosine A2 receptor.
    Keen M; Kelly E; Nobbs P; MacDermot J
    Biochem Pharmacol; 1989 Nov; 38(21):3827-33. PubMed ID: 2597174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-ethylmaleimide on adenosine receptors of rat fat cells and human platelets.
    Ukena D; Poeschla E; Hüttemann E; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):247-53. PubMed ID: 6092976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of binding sites for [3H]cyclohexyladenosine in the hippocampus and other regions of rat brain: a quantitative autoradiographic study.
    Erfurth A; Reddington M
    Neurosci Lett; 1986 Feb; 64(1):116-20. PubMed ID: 3008036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labelling of Ri adenosine receptors in rat fat cell membranes with (-)-[125iodo]N6-hydroxyphenylisopropyladenosine.
    Ukena D; Furler R; Lohse MJ; Engel G; Schwabe U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):233-40. PubMed ID: 6089004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic carbamazepine down-regulates adenosine A2 receptors: studies with the putative selective adenosine antagonists PD115,199 and PD116,948.
    Elphick M; Taghavi Z; Powell T; Godfrey PP
    Psychopharmacology (Berl); 1990; 100(4):522-9. PubMed ID: 2157232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of the anticonvulsant carbamazepine with adenosine receptors. 2. Pharmacological studies.
    Skerritt JH; Johnston GA; Chow SC
    Epilepsia; 1983 Oct; 24(5):643-50. PubMed ID: 6311526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific and potent interactions of carbamazepine with brain adenosine receptors.
    Marangos PJ; Post RM; Patel J; Zander K; Parma A; Weiss S
    Eur J Pharmacol; 1983 Sep; 93(3-4):175-82. PubMed ID: 6315450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.